Synonyms: ChAglyCD3 | TRX4
Compound class:
Antibody
Comment: Otelixizumab is a chimeric humanized IgG1 monoclonal antibody targeting the CD3E component of the T cell receptor. The antibody is aglycosylated. Otelixizumab was investigated as a potential treatment for autoimmune diseases including type I diabetes [3-4].
Peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
8864 | otelixizumab |
Synonyms |
ChAglyCD3 | TRX4 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 235 |
Other databases | |
GtoPdb PubChem SID | 252166668 |
Search PubMed clinical trials | otelixizumab |
Search PubMed titles | otelixizumab |
Search PubMed titles/abstracts | otelixizumab |
Wikipedia | Otelixizumab |